Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
Health Care & Life Sciences
Articles
Debunking medical myths all in a day’s work for IU’s Dr. Aaron Carroll
Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.
Groups protest insulin prices outside Lilly headquarters
Several diabetes and health care advocacy groups on Thursday announced a seven-figure fundraising campaign to help fund their fight against what they consider “skyrocketing” insulin prices.
Lilly’s push into pain research starting to pay off
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
Lilly pain drug wins approval to treat cluster headaches
It’s the second approved use for Emgality, which first won U.S. approval last fall to treat migraines. Analysts predict it could become a blockbuster.
Sandy Eskenazi donates $5 million to Eskenazi Health
To recognize the contribution, Eskenazi Health is changing the name of Midtown Community Mental Health to the Sandra Eskenazi Mental Health Center.
2019 Innovation Issue: Hospitals move cautiously into AI
The medical field’s lofty dreams of unleashing the power of artificial intelligence to transform medicine have yet to materialize in a major way.
Questions loom over proposed Carmel rehabilitation hospital
Two out-of-state companies that want to build a 60-bed hospital in Carmel have a history of mass layoffs, at least one high-profile bankruptcy, and accusations of kickbacks and billing irregularities.
Indiana joining other states in nursing licensing exchange
Indiana will recognize nursing licenses from most other states with a new law taking effect this summer.
Bioanalytical Systems buys toxicology firm
Bioanalytical Systems said May 1 it purchased Smithers Avanza Toxicology Services in suburban Washington, D.C.
Panelists discuss funding startups, attracting talent
Panelists from a broad range of life sciences fields shared their insights on key issues during IBJ's Life Sciences Power Breakfast on May 3.
Recently launched research institute pursuing life science innovations through ‘team science’
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
Tennessee real estate firm pays $47M for Methodist building
The seller was The Sanders Trust of Birmingham, Alabama. The trust—co-founded by Hall of Fame National Football League quarterback Bart Starr—acquired the building in 2009.
Elanco agrees to buy pet-drug developer for $234 million
Kansas-based Aratana Therapeutics has three treatments approved by the U.S. Food and Drug Administration and is working on drugs for a range of disease fields, including cancer.
Lilly creates public downtown park on edge of its headquarters campus
The city’s newest park is springing up on the south side of downtown, a district quickly filling up with apartments, offices and retail—and a noticeable shortage of public green space.
Anthem tops quarterly expectations, raises 2019 forecast
The nation's second largest insurer said Wednesday that enrollment in its fully-insured coverage jumped more than 6%, to 15.3 million.
Hospitals sue over new national liver transplant policy
Hospitals and patients have sued to block a new nationwide liver transplant policy that they say will waste viable livers, lead to fewer transplants and likely cause deaths.
McConnell proposes national minimum age of 21 for tobacco
Senate Majority Leader Mitch McConnell said Thursday his bill will cover all tobacco products, including vaping devices.
Lilly bets billions on focus on cancer drugs
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.